“Many people with high-function depression are chasing goals that are mostly materialistic, like getting an accolade or ...

Harvard researchers have found that M. morganii may contribute to depression by producing an inflammatory molecule.

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

While there are many treatment options for depression, natural remedies, self-care methods, and alternative therapies can ...

A compelling new study is building on a growing body of evidence showing a common exercise supplement used to build muscle ...

A new study from the University of Chicago Medicine reveals that people with alcohol use disorder (AUD) and depression experience high levels of stimulation and pleasure when intoxicated, similar to ...

People with bipolar I disorder have had at least one manic episode preceded or followed by hypomanic or major depressive ...

Depressed drinkers experience alcohol’s pleasure and stimulation, challenging beliefs about self-medication and addiction.

In JASA Express Letters, researchers develop machine learning tools that screen for comorbid anxiety disorders and major ...

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) amended its agreement with Takeda Pharmaceutical Co Ltd (NYSE:TAK) to develop and ...

Neurocrine Biosciences amended its agreement with Takeda Pharmaceutical regarding the development and commercialization of osavampator, a treatment for major depressive disorder.

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.